(Q71128851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

J B Epstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

A Ransier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

R Lunn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

E Chin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J J Jacobson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

N Le

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

D Reece

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

291-296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy-associated oral infections in adults with solid tumors.

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Orofacial aspergillosis in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Oral Candida albicans in bone marrow transplant patients given chlorhexidine rinses: occurrence and susceptibilities to the agent

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

The outlook for antifugal prophylaxis in the compromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Evaluation of nystatin in prevention and elimination of oropharyngeal Candida in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Treatment of Oral Candidiasis in Debilitated Patients with Miconazole—a New Potent Antifungal Drug

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Survival of patients with polycythemia vera on busulfan or 32P

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Nystatin Prophylaxis in Leukemia and Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Efficacy of Ketoconazole v Nystatin in Prevention of Fungal Infections in Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

The effect of amphotericin B lozenges on the presence and number of Candida cells in the oropharynx of neutropenic leukemia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Therapeutic use of chlorhexidine in bone marrow transplant patients: case studies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Prophylaxis of Oral Candidiasis With Clotrimazole Troches

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Azole antifungal agents: emphasis on new triazoles

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Systemic fluconazole therapy and in vitro adhesion of Candida albicans to human buccal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Absence of significant interaction of fluconazole with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Oral candidiasis: effects of antifungal therapy upon clinical signs and symptoms, salivary antibody, and mucosal adherence of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Development of resistance in candida isolates from patients receiving prolonged antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Fluconazole-resistant Candida in AIDS patients. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Antifungal susceptibility tests

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980328-3

7 January 2021

10.1016/S1079-2104(96)80328-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8653462%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference